Nuclear imaging tracer under development to benefit tumour biopsies

Share this on social media:

An injectable tracer that can provide both nuclear imaging in the pre-operative evaluation of tumours and optical imaging during ablation or biopsy is being developed by CEA-Leti and four French partners.

The three-year Nano-ENO project is developing a specific tracer using a patented organic nano-carrier (Lipidot).

When treating cancer, medical professionals often look to several diagnostic tools and surgical aids, including positron emission tomography (PET) scan and fluorescence imaging.

The nuclear markers used in a PET scan help provide high-resolution images, while optical contrast agents facilitate the identification of tumour cells in real-time. Combining these imaging technologies makes it possible to confirm that the tumours being operated on correspond to the tumours identified in the pre-operative studies. It also allows for a more thorough procedure to be performed with reduced overall surgical time; not only can the surgeon work more quickly and with greater precision, but the entire operation is streamlined, allowing for a more efficient use of operating rooms and surgical staff.

Recent News

27 May 2021

The vision devices use Sony's IMX500 sensor, which is able to run AI algorithms on the chip to provide real-time information about free parking spaces and other transport data

12 February 2021

Video recorded at 2,800 frames per second has been used to test high-speed trains travelling through the newly opened Ceneri Base Tunnel in Switzerland

29 July 2020

The Perseverance rover contains 19 cameras, including seven scientific instruments. It will analyse the climate and geology of Mars, looking for signs of past life, as well as monitoring the Martian atmosphere

02 July 2020

Norwegian seafood firm, Lerøy, has installed hyperspectral cameras on processing lines to sort fish. The system is able to measure the amount of blood in white fish, which gives a grade of quality